logo

COVID-19: Drugs in Development

Share

The COVID-19 outbreak, which started in December 2019 in Wuhan City, China, was declared a "Public Health Emergency of International Concern" by the WHO on January 30, 2020. The outbreak was characterized as a pandemic on March 11, 2020.

Currently, there are no drugs to treat COVID-19, caused by the novel coronavirus SARS-CoV-2.

Listed below are companies that are in the race to find a treatment or vaccine for the novel coronavirus.

Subscribe to RTT Intelligent Investor for FREE 7-Day Trial with complete access to COVID-19 Drugs in Development Calendar.

Company Name
Drug
Current Stage
Next Milestone
Collaboration
Last Updated
Incyte Corporation
(INCY)
OLUMIANT
Phase 3 trial of Olumiant in hospitalized participants with COVID-19, dubbed COV-BARRIER
Results expected in December 2020
Lilly
10/19/2020
Incyte Corporation
(INCY)
Jakafi
Phase 3 trial of Jakafi in patients with COVID-19-associated Acute Respiratory Distress Syndrome who require mechanical ventilation (RUXCOVID-DEVENT)
-
-
10/19/2020
Relief Therapeutics Holding AG
(RLFTF. OB)
RLF-100
US Phase 2b/3 clinical trials of RLF-100 in respiratory deficiency due to COVID-19
Topline data expected in Q4, 2020
-
10/13/2020
Altimmune Inc.
(ALT)
AdCOVID Intranasal Covid-19 vaccine
Positive results from the preclinical studies of AdCOVID announced on Jul.13
Phase 1 clinical trial of AdCOVID in Q4 2020
Vigene Biosciences, DynPort Vaccine Co.
10/13/2020
HUMANIGEN, INC
(HGEN)
Lenzilumab
Phase III trial of Lenzilumab in severe and critical COVID-19 patients
Topline data expected in Q4, 2020
-
10/09/2020
Hepion Pharmaceuticals, Inc.
(HEPA)
CRV431
Preclinical stage
-
National Institute of Allergy and Infectious Diseases
10/09/2020
Immunic, Inc
(IMUX)
IMU-838 for COVID-19.
Phase 2b study in combination with Tamiflu in adult patients with moderate-to-severe COVID-19 (IONIC)
Top-line data expected later in 2020
University Hospitals Coventry and Warwickshire NHS Trust
09/28/2020

Get Full Access to latest records of COVID-19 Drugs in Development Calendar by subscribing to RTT Intelligent Investor with FREE 7-Day Trial. (No Credit Card Required)

Editors Pick
Orca Bay Foods, LLC recalled about 4,450 pounds of Trader Joe's brand Gluten Free Battered Halibut products for undeclared wheat and milk allergens, according to a statement published by the U.S. Food and Drug Administration (FDA). The action was initiated after it was discovered that product containing Wheat and Milk was distributed in packaging. Lee Kun-hee, the Chairman of South Korean conglomerate Samsung Group, has died on October 25, at the age of 78. It was he who transformed Samsung into a South Korean behemoth, and the world's largest manufacturer of smartphones, televisions, and semiconductors. As per reports, Lee's only son Jae-yong, who currently serves as vice chairman of Samsung Electronics, is likely to take over Samsung. Toy and board game company Hasbro, Inc. (HAS) reported Monday net earnings attributable to Hasbro for the third quarter of $220.90 million or $1.61 per share, compared to pro forma net earnings of $216.5 million or $1.57 per share in the year-ago period. Excluding items, adjusted earnings for the...